We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 137

Ninth Circuit affirms divestiture of consummated physician practice acquisition
  • McDermott Will & Emery
  • USA
  • February 27 2015

The U.S. Court of Appeals for the Ninth Circuit affirmed an Idaho federal district court’s decision ordering the divestiture of a physician practice


The case of ophthalmic drugs in Italy and France: a lesson to learn - parallel antitrust investigations and cooperation between national competition authorities
  • McDermott Will & Emery
  • European Union, France, Italy
  • May 7 2014

The recent investigations into two pharmaceutical companies active in the ophthalmic drugs market in Italy and France serve as a reminder of the


Massachusetts Court Weighs in on Product Hopping Allegations and Reverse Payment Standing
  • McDermott Will & Emery
  • USA
  • November 11 2016

Addressing a motion to dismiss a bevy of antitrust allegations, the US District Court for the District of Massachusetts held that a class of


Focus on regulatory law - October 2014
  • McDermott Will & Emery
  • France
  • October 3 2014

The applicant claimed that the provisions of I, Article L. 430-8 of the French Commercial Code, which allows the Competition Authority to fine


Court certifies class in hospital merger antitrust lawsuit
  • McDermott Will & Emery
  • USA
  • December 19 2013

On December 10, 2013, Judge Edmond Chang of the Northern District of Illinois certified a class of plaintiffs who filed a proposed class action


Sham-wow! antitrust liability may attach to sham administrative petitions
  • McDermott Will & Emery
  • USA
  • October 1 2014

Addressing whether the “sham” exception to Noerr-Pennington immunity is limited to sham litigation in courts, the U.S. Court of Appeals for the


North Carolina dentists seek rehearing en banc after losing bid for antitrust immunity
  • McDermott Will & Emery
  • USA
  • July 19 2013

North Carolina's dentists were not smiling when a three judge panel of the U.S. Court of Appeals for the Fourth Circuit sided with the Federal Trade


Second Circuit to hear expedited appeal in “product hopping” suit
  • McDermott Will & Emery
  • USA
  • January 9 2015

On January 6, 2015, the Second Circuit granted defendants’ motion for an expedited appeal but denied their motion for a stay in New York v


Federal judge puts narcolepsy drug horizontal conspiracy claims to bed
  • McDermott Will & Emery
  • USA
  • June 27 2014

On Monday, June 23, 2014, a Federal Judge in the Eastern District of Pennsylvania granted summary judgment for five pharmaceutical companies on


Supreme Court limits availability of state action immunity from federal antitrust liability
  • McDermott Will & Emery
  • USA
  • February 20 2013

The Supreme Court decision in FTC v. Phoebe Putney Health System, Inc., makes clear that state action immunity from federal antitrust laws is